Pharmaceutics 2027
From Biopharmaceutics to Clinical Pharmaceutics
the chair
Welcome from the Chair
Dear Colleagues,
It is my great pleasure to welcome you to Pharmaceutics 2027 – From Biopharmaceutics to Clinical Pharmaceutics, taking place in Barcelona, Spain from 28–30 June 2027. This milestone conference brings together leading researchers, clinicians, industry professionals, and innovators from across the globe to exchange cutting-edge knowledge, discuss emerging trends, and forge vital partnerships across the pharmaceutical sciences.
The theme of this year's conference reflects our ambition to explore the entire continuum of pharmaceutical development. We will span the full spectrum from the fundamental principles of biopharmaceutics and innovative drug formulation to advanced drug delivery systems, pharmaceutical manufacturing, translational research, and clinical applications. Through an engaging program of keynote lectures, oral presentations, interactive poster sessions, and curated networking events, participants will gain deep insights into the latest scientific breakthroughs and the regulatory or technical challenges shaping the future of our field.
Pharmaceutics 2027 aims to provide a dynamic, interdisciplinary platform. We actively encourage researchers from academia, industry, and healthcare sectors to participate—whether by presenting groundbreaking work, sharing unique technical expertise, or engaging in the vibrant discussions that drive innovation and ultimately improve patient outcomes.
Beyond the formal scientific sessions, the conference offers invaluable opportunities to establish fresh alliances, strengthen global professional networks, and connect with peers who give our international community its collective scientific weight.
I look forward to welcoming you to Barcelona for what promises to be an inspiring, collaborative, and highly productive conference.
Sincerely,
Prof. Dr. Patrick J. Sinko
Pharmaceutics 2027 Chair
Join us on LinkedIn Events!
If you want to stay updated with the latest information, or if you want to connect with your fellow researchers before, during, and after the event, then be sure to join the Pharmaceutics 2027 – From Biopharmaceutics to Clinical Pharmaceutics LinkedIn Event.
See you over there!
Follow the conversation on X with #Pharmaceutics2027
Meet Our Chair
Rutgers - The State University of New Jersey, USA;Prof. Dr. Patrick J. Sinko is a Pharmacist and a Pharmaceutical Scientist at Rutgers, The State University of New Jersey. He is a Distinguished Professor and the Parke-Davis Endowed Chair in Pharmaceutics and Drug Delivery at the Ernest Mario School of Pharmacy. Dr. Sinko has authored or co-authored over 540 research papers, abstracts, and book chapters. He was elected a Fellow of the American Association for the Advancement of Science, the American Association of Pharmaceutical Scientists, the Controlled Release Society, and the National Academy of Inventors. Dr. Sinko was also elected to serve on the Council of the AAAS and the Board of Scientific Advisors of the Controlled Release Society. Dr. Sinko testified before the United States Congress at the US-China Economic and Security Review Commission hearing on China’s Pursuit of Next Frontier Tech: Computing, Robotics, and Biotechnology. He was the Founding Chair of the Nanotechnology Focus Group and the 2022-2023 President of AAPS. Dr. Sinko is a member of numerous advisory committees and boards, including the Research Advisory Committee for the Dr. Susan Love Research Foundation. He is the Editor of Martin’s Physical Pharmacy and Pharmaceutical Sciences (Fifth, Sixth, Seventh, and Eighth Editions) and is on the Editorial Advisory Board for numerous journals. He is the Principal Investigator of an active research laboratory that focuses on biopharmaceutics, pharmaceutical formulations, and molecular-, nano-, and micro-scale drug delivery with specific applications to the treatment or prevention of HIV/AIDS, breast and lung cancer, glioblastoma multiforme, chemical terrorism countermeasures, and TB. During his career, Dr. Sinko has received several awards for his teaching and research, including the Rutgers University Board of Trustees Award for Excellence in Research and the highly selective National Institutes of Health FIRST and MERIT Awards.
Ms. Dusica Radovanovic
Ms. Roberta Miglioranza
Ms. Ashia Carcallas
Ms. Marie-France Watson
Email: pharmaceutics2027@mdpi.com
Important Dates
20 Jul
2026
29 Jan
2027
1 Mar
2027
5 Apr
2027
26 May
2027
23 Jun
2027
23 Jun
2027
Meet Our Speaker
University of Alberta, Canada;Dr. Neal M. Davies received his undergraduate degree in Pharmacy from the University of Alberta in 1991. In 1996, he completed his Ph.D. in pharmaceutical sciences, specializing in pharmacokinetics, at the University of Alberta. From 1995 to 1998, he undertook postdoctoral training in pharmacology and toxicology at the University of Calgary. He then joined the University of Sydney as a lecturer in 1998. In 2002, he returned to North America to join the Washington State University’s (WSU) College of Pharmacy as an academic staff member, where he has held the positions of Director of the Pharmaceutical Sciences Graduate Program, as well as Director of Professional and Undergraduate Research and Director of Summer Undergraduate Research Fellowship program. He was active on numerous university-wide committees, including service as a member of WSU’s Faculty Senate and Chair of the Institutional Animal Care and Use Committe. From 2011-2016 he was Dean of the Faculty of Pharmacy at the University of Manitoba. Throughout his career, Dr. Davies has strived to maintain the highest standard of teaching and research, and his achievements in both areas have been recognized through numerous awards and honours including several from the United States Pharmacopeia and the Canadian Society of Pharmaceutical Sciences. He has taught at the undergraduate and graduate levels, and has an ongoing and significant commitment toward graduate supervision and training. He has been at the forefront of the use of technology in the classroom, has re-engineered curricular content and maintained a high standard in student mentoring. Dr. Davies also maintains an active and highly collaborative externally-funded research program, focused on pharmacokinetics and drug delivery as well as basic and clinical pharmaceutical sciences which have attracted National Institutes of Health and Industry funds.
Exhibitor and Partner Opportunities
We invite your organization to become part of Pharmaceutics 2027 and connect with a focused international audience working in pharmaceutical sciences. Industry participants will have the opportunity to engage with the scientific community, demonstrate relevant tools and services, and build connections with researchers, practitioners, and other organizations active in the field.
We are currently developing a range of industry participation and partnership opportunities designed to support different goals, from conference attendance and exhibitor presence to enhanced engagement, visibility, and support for specific conference activities. Further details, including our industry participation prospectus, will be made available shortly.
If you have any questions or would like to discuss how your organization could become involved in Pharmaceutics 2027, please contact us at pharmaceutics2027@mdpi.com. We look forward to sharing further details and exploring suitable participation options with you.
Society Collaboration
Are you part of a society and interested in this conference? Contact us to discuss a media partnership where your society members can access a 20% discount on all registration fees!
